Thermo Fisher Scientific (TMO) Stock Chart - Revenue & Earnings | Quarter Chart
Revenue by Product
Revenue by Geography
Revenue, Gross Profit, Operating and Net Income
Margin (%)
Operating Expenses
EBITDA
EPS
Revenue Variation (%)
Income Variation (%)
Revenue YoY Variation (%)
Income YoY Variation (%)
Price-to-Earning Ratio
Income Breakdown
Per Share Metrics
Expense Ratios
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt Ratio
Current Ratio
Quick Ratio
Cash & Equivalents
Total Assets
Total Liabilities
Shareholders Equity
Asset Composition
Debt Structure
Thermo Fisher Scientific (TMO) quarterly earnings & revenue
Thermo Fisher Scientific (TMO) reported revenue of $11.99B for Q2 2026, up 10.5% year-over-year, with net income of $1.74B and diluted EPS of $4.68.
Over the last four reported quarters, Thermo Fisher Scientific generated $46.34B in revenue and $6.98B in net income.
Thermo Fisher Scientific's next earnings report is scheduled for October 28, 2026 before market open; analysts estimate EPS of $6.36.
Thermo Fisher Scientific quarterly results
| Fiscal quarter | Revenue | Revenue YoY | Net income | EPS (diluted) |
|---|---|---|---|---|
| Q2 2026 | $11.99B | +10.5% | $1.74B | $4.68 |
| Q1 2026 | $11.01B | +6.2% | $1.65B | $4.43 |
| Q4 2025 | $12.21B | +7.2% | $1.98B | $5.21 |
| Q3 2025 | $11.12B | +4.9% | $1.62B | $4.27 |
| Q2 2025 | $10.86B | +3.0% | $1.62B | $4.28 |
| Q1 2025 | $10.36B | +0.2% | $1.51B | $3.98 |
| Q4 2024 | $11.39B | +4.7% | $1.83B | $4.78 |
| Q3 2024 | $10.60B | +0.2% | $1.63B | $4.24 |
Thermo Fisher Scientific (TMO) — frequently asked questions
When does Thermo Fisher Scientific (TMO) report earnings next?
Thermo Fisher Scientific is expected to report earnings on October 28, 2026 before market open. Analysts estimate EPS of $6.36.
What was TMO's revenue last quarter?
Thermo Fisher Scientific reported revenue of $11.99B in Q2 2026, up 10.5% from the same quarter a year earlier.
What was TMO's EPS last quarter?
Thermo Fisher Scientific reported diluted EPS of $4.68 in Q2 2026.
Is Thermo Fisher Scientific profitable?
Thermo Fisher Scientific is currently profitable, with $6.98B in net income over the last four reported quarters.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Merck (MRK) · Roche (ROG.SW)